UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Parkinsonism in viral, paraneoplastic, and autoimmune diseases

Journal of the neurological sciences, 2022-02, Vol.433, p.120014-120014, Article 120014

2022

Volltextzugriff (PDF)

Medications used to treat tremors

Journal of the neurological sciences, 2022-04, Vol.435, p.120194-120194, Article 120194

2022

Volltextzugriff (PDF)

Editorial “Parkinsonism across the spectrum of movement disorders and beyond”

Journal of the neurological sciences, 2022-02, Vol.433, p.120013-120013, Article 120013

2022

Volltextzugriff (PDF)

Levodopa-induced dyskinesia: clinical features, incidence, and risk factors

Journal of Neural Transmission, 2018-08, Vol.125 (8), p.1109-1117

2018

Volltextzugriff (PDF)

Orofacial dystonia and associated bulbar symptoms in multiple system atrophy: A blinded video analysis

Journal of the neurological sciences, 2020-10, Vol.417, p.116995-116995, Article 116995

2020

Volltextzugriff (PDF)

Setting the record straight: The nosology of tardive syndromes

Parkinsonism & related disorders, 2019-02, Vol.59, p.146-150

2019

Volltextzugriff (PDF)

The nosology of tardive syndromes

Journal of the neurological sciences, 2018-06, Vol.389, p.10-16

2018

Volltextzugriff (PDF)

Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders

Toxicon (Oxford), 2013-06, Vol.67, p.94-114

2013

Volltextzugriff (PDF)

Hallucinations and the spectrum of psychosis in Parkinson's disease

Journal of the neurological sciences, 2017-03, Vol.374, p.56-62

2017

Volltextzugriff (PDF)

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial

JAMA neurology, 2017-08, Vol.74 (8), p.941

2017

Volltextzugriff (PDF)

Multiple system atrophy: Diagnostic challenges and a proposed diagnostic algorithm

Clinical parkinsonism & related disorders, 2024-01, Vol.11, p.100271, Article 100271

2024

Volltextzugriff (PDF)

Amiloride but not memantine reduces neurodegeneration, seizures and myoclonic jerks in rats with cardiac arrest-induced global cerebral hypoxia and reperfusion

PloS one, 2013-04, Vol.8 (4), p.e60309-e60309

2013

Volltextzugriff (PDF)

Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders

Toxicon (Oxford), 2013-06, Vol.67, p.141-152

2013

Volltextzugriff (PDF)

Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN® , botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia

Journal of the neurological sciences, 2011-09, Vol.308 (1), p.103-109

2011

Volltextzugriff (PDF)

Role of Gα(olf) in familial and sporadic adult-onset primary dystonia

Human molecular genetics, 2013-06, Vol.22 (12), p.2510-2519

2013

Volltextzugriff (PDF)

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

CNS drugs, 2018-04, Vol.32 (4), p.387-398

2018

Volltextzugriff (PDF)

Management of non-motor symptoms in advanced Parkinson disease

Journal of the neurological sciences, 2008-03, Vol.266 (1), p.216-228

2008

Volltextzugriff (PDF)

Current clinical applications of botulinum toxin

Current pharmaceutical design, 2009-11, Vol.15 (31), p.3671-3680

2009

Volltextzugriff (PDF)

The sleeping brain in Parkinson's disease: A focus on REM sleep behaviour disorder and related parasomnias for practicing neurologists

Journal of the neurological sciences, 2017-03, Vol.374, p.32-37

2017

Volltextzugriff (PDF)

Role of G[alpha](olf) in familial and sporadic adult-onset primary dystonia

Human molecular genetics, 2013-06, Vol.22 (12), p.2510-2519

2013

Volltextzugriff (PDF)

Biology of prodromal Parkinson's disease

Journal of the neurological sciences, 2021-10, Vol.429, p.117985, Article 117985

Truong, Daniel

2021

Volltextzugriff (PDF)

Eye movement abnormalities in movement disorders

Clinical parkinsonism & related disorders, 2019-01, Vol.1, p.54-63

2019

Volltextzugriff (PDF)

Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystonia

Clinical parkinsonism & related disorders, 2022-01, Vol.7, p.100160-100160, Article 100160

2022

Volltextzugriff (PDF)

Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease

Parkinsonism & related disorders, 2019-07, Vol.64, p.175-180

2019

Volltextzugriff (PDF)

International Neurology

Second edition., 2016

Volltextzugriff (PDF)

1 – 25 von 1.386

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(897)
Mit Volltextzugriff
(1.063)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(643)
Life Sciences & Biomedicine
(444)
Humans
(310)
Male
(168)
Female
(149)
Neurosciences & Neurology
(140)
Technology
(138)
Clinical Neurology
(121)
Middle Aged
(109)
Physical Sciences
(108)
Animals
(96)
Biological And Medical Sciences
(88)
Adult
(81)
Aged
(78)
Medical Sciences
(73)
Neurology
(73)
Chemistry
(68)
Neurosciences
(68)
Science & Technology - Other Topics
(57)
Materials Science
(50)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of The Neurological Sciences
(35)
Movement Disorders
(30)
Neurology
(20)
Parkinsonism & Related Disorders
(16)
Circulation
(15)
Clinical Parkinsonism & Related Disorders
(15)
Toxicon
(14)
Bioorganic & Medicinal Chemistry Letters
(12)
Solar Rrl
(12)
Plos One
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Parkinsonism in viral, paraneoplastic, and autoimmune diseases

Medications used to treat tremors

Editorial “Parkinsonism across the spectrum of movement disorders and beyond”

Levodopa-induced dyskinesia: clinical features, incidence, and risk factors

Orofacial dystonia and associated bulbar symptoms in multiple system atrophy: A blinded video analysis

Setting the record straight: The nosology of tardive syndromes

The nosology of tardive syndromes

Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders

Hallucinations and the spectrum of psychosis in Parkinson's disease

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial

Multiple system atrophy: Diagnostic challenges and a proposed diagnostic algorithm

Amiloride but not memantine reduces neurodegeneration, seizures and myoclonic jerks in rats with cardiac arrest-induced global cerebral hypoxia and reperfusion

Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders

Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN® , botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia

Role of Gα(olf) in familial and sporadic adult-onset primary dystonia

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

Management of non-motor symptoms in advanced Parkinson disease

Current clinical applications of botulinum toxin

The sleeping brain in Parkinson's disease: A focus on REM sleep behaviour disorder and related parasomnias for practicing neurologists

Role of G[alpha](olf) in familial and sporadic adult-onset primary dystonia

Biology of prodromal Parkinson's disease

Eye movement abnormalities in movement disorders

Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystonia

Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease

International Neurology

Suchergebnisse filtern